Related Experiment Video
Updated: Aug 9, 2026

Mouse Embryonic Development in a Serum-free Whole Embryo Culture System
Published on: March 1, 2014
Growth factor function of vasoactive intestinal peptide in whole cultured mouse embryos
P Gressens1, J M Hill, I Gozes
1Laboratory of Experimental Neuropathology, National Institute of Neurological Disorders and Stroke, National Institute of Child Health and Human Development, Bethesda, Maryland 20892.
Abstract:
Factors controlling central nervous system (CNS) growth immediately after neurulation are mostly unknown. Vasoactive intestinal peptide (VIP) receptors are widely distributed in the embryonic nervous system, and VIP has trophic and mitogenic properties on embryonic neural tissues but inhibits growth and mitosis in certain tumours. To address the potential effects of VIP on embryonic growth, we used whole postimplantation embryo cultures. After a 4-h incubation, VIP stimulated growth, increasing somite number, embryonic volume, DNA and protein content, and number of cells in S-phase. A VIP antagonist substantially inhibited these VIP-mediated increments in growth. The VIP antagonist completely suppressed VIP-stimulated mitosis in the CNS while decreasing the same in non-neuronal tissues by 38%. In vitro autoradiography revealed GTP-sensitive and GTP-insensitive VIP receptors which were differentially regulated in VIP antagonist-treated embryos. The present study suggests that VIP acts as a growth factor on early postimplantation embryos through multiple VIP receptors that exhibit tissue-specific responses.
Insights
Vasoactive intestinal peptide (VIP) acts as a growth factor in early embryonic development, promoting central nervous system (CNS) growth and cell proliferation. A VIP antagonist inhibited these growth-promoting effects, highlighting VIP
Area of Science:
- Developmental Biology
- Neuroscience
- Endocrinology
Background:
- Factors regulating early central nervous system (CNS) growth post-neurulation remain largely unknown.
- Vasoactive intestinal peptide (VIP) receptors are prevalent in the embryonic nervous system, with known trophic and mitogenic effects on neural tissues, yet inhibitory effects on certain tumors.
Purpose of the Study:
- To investigate the role of VIP in embryonic growth during early postimplantation development.
- To determine the impact of VIP on CNS growth and cell division.
Main Methods:
- Whole postimplantation embryo cultures were utilized for experimentation.
- Vasoactive intestinal peptide (VIP) and a VIP antagonist were administered to assess their effects on embryonic growth parameters.
- In vitro autoradiography was employed to characterize VIP receptors.
Main Results:
- VIP significantly stimulated embryonic growth, evidenced by increased somite number, embryonic volume, DNA and protein content, and S-phase cells after 4-hour incubation.
- A VIP antagonist markedly inhibited VIP-mediated growth increments and completely suppressed VIP-stimulated mitosis in the CNS.
- VIP antagonist treatment decreased mitosis in non-neuronal tissues by 38% and revealed differential regulation of GTP-sensitive and GTP-insensitive VIP receptors.
Conclusions:
- Vasoactive intestinal peptide (VIP) functions as a critical growth factor in early postimplantation embryos.
- VIP exerts its growth-promoting effects via multiple VIP receptors, demonstrating tissue-specific responses.
- The findings elucidate a novel role for VIP in regulating embryonic CNS development.
More Related Videos
Related Concept Videos
Renewal of Intestinal Stem Cells
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...

